Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Radiology, Department of"
  3. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (12)
Groups
  1. Department of Medicine (25)
  2. Nursing (25)
  3. Radiology, Department of (25)
  4. Solid Tumor Oncology Division (25)
  5. Epidemiology and Biostatistics (23)
  6. Biostatistics Service (21)

More Groups

People
  1. Zsofia Stadler (8)
  2. Ellen Hollywood (6)
  3. Mary Ellen Moynahan (6)
  4. Anas Younes (5)
  5. Andrew Zelenetz (5)
  6. David Straus (5)

More People

Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2019 (3)
  4. 2018 (2)
  5. 2017 (2)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Blood (3)
  3. Clinical Cancer Research (2)
  4. Cancer (1)
  5. Cancer Immunology Research (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (4)
  3. American Society of Hematology (3)
  4. Wiley Blackwell (2)
  5. American Medical Association (1)
  6. Elsevier Inc. (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer
    Journal Article

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Lamendola-Essel, M.; El Dika, I. H.; Segal, N.; Shcherba, M.; Sugarman, R.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save